Description
GLP-1/GIP Receptor Agonist – 60mg Vial
A cutting-edge dual-agonist formulation designed to activate both GLP-1 and GIP receptors, supporting effective weight loss and blood sugar control. Modeled after the active ingredient in Mounjaro (tirzepatide), this peptide-based injectable helps regulate appetite, improve insulin sensitivity, and enhance metabolic function. Ideal for clinical research or therapeutic programs focused on diabetes and obesity management.
Reviews
There are no reviews yet.